- Sera Prognostics Shares Up 45% After Positive Trial Results Released MarketWatch
- Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL Yahoo Finance
- SERA stock jumps as study for preterm birth test succeeds (NASDAQ:SERA) Seeking Alpha
- View Full Coverage on Google News
Source link